SIG
MYOK

Stanford Investment Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Stanford Investment Group’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,200
Closed -$41K – 334
2016
Q4 		$41K Hold
3,200
– – 0.02% 161
2016
Q3 		$52K Hold
3,200
– – 0.02% 149
2016
Q2 		$40K Hold
3,200
– – 0.02% 165
2016
Q1 		$34K Buy
+3,200
New +$29.1K 0.02% 184

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Stanford Investment Group's MYOK Position: Q1 2017 in Review

Stanford Investment Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q1 2017, closing a stake of 3,200 shares — an estimated $41K sold.

Stanford Investment Group first reported a position in MYOK in Q1 2016 and held it in 4 quarters. The position peaked at $52K in Q3 2016. 73 funds tracked by Wall St. Rank hold MYOK as of Q1 2017.

  • Stanford Investment Group reported no remaining MyoKardia, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Stanford Investment Group sold 3,200 MyoKardia, Inc. Common Stock shares in Q1 2017, an estimated $41K.
  • Stanford Investment Group first reported a position in MyoKardia, Inc. Common Stock in Q1 2016 and held it in 4 quarters.
  • Stanford Investment Group's MyoKardia, Inc. Common Stock position peaked at $52K in Q3 2016.
  • 73 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q1 2017.

Based on Stanford Investment Group's 13F filing for Q1 2017.